Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges.

Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges.
复制标题

DOI:
10.1002/mgg3.2245
复制
发表时间:
2023-11
影响因子:
2
通讯作者:
--
中科院分区:
医学4区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

工作场所基因和/或基因组检测(wGT)是雇主可以在自愿工作场所健康计划范围内提供的众多选择之一,尽管我们对有多少雇主提供这种福利知之甚少,或者包括哪些类型的检测。我们的景观审查试图发现wGT的流行和分布在自愿健康计划在美国公司使用三种方法:(1)分析公开信息;(2)全国调查;(3)采访公司代表。总体而言,我们调查的420家公司中有50家(11.9%)有公开数据表明他们向员工提供wGT。代表美国公司类型和分布的加权调查数据显示,约1%的美国公司向员工提供wGT。我们的研究发现,几乎没有证据表明美国公司广泛采用wGT,尽管信息收集具有挑战性。工作场所基因和/或基因组检测(wGT)是雇主可以在自愿工作场所健康计划范围内提供的众多选择之一,尽管我们对有多少雇主提供这种福利知之甚少,或者包括哪些类型的检测。我们的景观审查试图发现wGT的流行和分布在自愿健康计划在美国公司使用三种方法:(1)分析公开信息;(2)全国调查;(3)采访公司代表。我们的研究发现,几乎没有证据表明美国公司广泛采用wGT,尽管信息收集具有挑战性。
Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. Our landscaping review sought to discover the prevalence and distribution of wGT within voluntary wellness programs among U.S. companies using three approaches: (1) analysis of publicly available information; (2) national surveys; and (3) interviews with company representatives. In total, 50/420 (11.9%) companies we investigated had publicly available data suggesting that they offer wGT to their employees. Survey data weighted to be representative of the type and distribution of U.S. companies suggest that ~1% of U.S. companies offer wGT to their employees. Our research found little evidence of broad uptake of wGT among U.S. companies, though information gathering was challenging. Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. Our landscaping review sought to discover the prevalence and distribution of wGT within voluntary wellness programs among U.S. companies using three approaches: (1) analysis of publicly available information; (2) national surveys; and (3) interviews with company representatives. Our research found little evidence of broad uptake of wGT among U.S. companies, though information gathering was challenging.
DOI: 10.3389/fgene.2021.643304
发表时间: 2021
影响因子: 3.7
作者:
Sanghavi K;Feero WG;Mathews DJH;Prince AER;Price LL;Liu ET;Brothers KB;Roberts JS;Lee C
通讯作者: Lee C
DOI: 10.1002/mgg3.1414
发表时间: 2020-10
影响因子: 2
作者:
McDonald WS;Wagner JK;Deverka PA;Woods LA;Peterson JF;Williams MS
通讯作者: Williams MS
DOI: 10.1080/19325037.2012.10599239
发表时间: 2012-01-01
影响因子: 1
作者:
Hui, Siu-kuen Azor;Engelman, Kimberly;Ellerbeck, Edward F.
通讯作者: Ellerbeck, Edward F.
DOI: 10.1038/s41525-021-00276-8
发表时间: 2022-01-20
影响因子: 5.3
作者:
Sanghavi K;Cohn B;Prince AER;Feero WG;Ryan KA;Spector-Bagdady K;Uhlmann WR;Lee C;Roberts JS;Mathews DJH
通讯作者: Mathews DJH
DOI: 10.1002/stem.132
发表时间: 2009-01-01
期刊: STEM CELLS
影响因子: 5.2
作者:
Regenberg, Alan C.;Hutchinson, Lauren A.;Mathews, Debra J. H.
通讯作者: Mathews, Debra J. H.